| ActRIIA | Activin type II receptor A |
| ActRIIB | Activin receptor type II |
| ActRIIB | Activin type II receptor B |
| AMPK | AMP-activated protein kinase |
| ATP | Adenosine triphosphate production |
| CDC | Centers for Disease Control and Prevention |
| FDA | Food and Drug Administration |
| FFM | Fat-free mass |
| FoxO1/3 | Forkhead transcription factors 1 and 3 |
| GDF11 | Growth differentiation factor 11 |
| GHRH | Growth hormone-releasing hormone |
| GHS-R1a | Growth hormone secretagogue receptor type 1a |
| GIP RA | Glucose-dependent insulinotropic polypeptide receptor agonist |
| GIP-1 | Glucagon-like peptide-1 |
| GIP/GLP-1 RA or dual agonist | Dual glucagon-like peptide-1 receptor/glucose-dependent insulinotropic polypeptide receptor agonist |
| GLP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 RAs | Glucagon-like peptide-1 receptor agonists |
| GR | Glucocorticoid receptor |
| HIV | Human immunodeficiency virus |
| IGF | Insulin-like growth factor |
| IL-6 | Interleukin 6 |
| JAK/STAT3 | Janus Kinase (JAK)/Signal Transducer and Activator of Transcription (STAT) 3 |
| LBM | Lean body mass |
| LC3 | Microtubule-associated protein 1 light chain 3 |
| mTORc1 | Mechanistic target of rapamycin complex 1 |
| MuRF1 | Muscle ring finger 1 |
| MyHC | Myosin heavy chain |
| MyoD | Myoblast determination protein 1 |
| MyoG | Myogenin |
| NFκB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NPY | Neuropeptide Y |
| NRF-1 | Nuclear respiratory factor 1 |
| NRF-3 | Nuclear respiratory factor 3 |
| Pax7 | Paired box gene 7 |
| PGC-1α | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| PI3K | Phosphatidylinositol-3 kinase |
| SARM | Selective androgen receptor modulator |
| SM | Skeletal muscle |
| SMAD2/3 | Small mother against decapentaplegic 2/3 |
| T2DM | Type 2 diabetes mellitus |
| TFAM | Mitochondrial transcription factor A |
| TNF-α | Tumor necrosis factor alpha |
| TSC2 | Tuberous sclerosis complex 2 |
| U.S. | United States |
| ULK1 | Unc-51-like kinase 1 |